Cargando…
Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data
Objectives: The aim of the present study was to construct a polygenic risk score (PRS) for poor survival among patients with stomach adenocarcinoma (STAD) based on expression of malignant cell markers. Methods: Integrated analyses of bulk and single-cell RNA sequencing (scRNA-seq) of STAD and normal...
Autores principales: | Zou, Qiyuan, Lv, Yufeng, Gan, Zuhuan, Liao, Shulan, Liang, Zhonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558465/ https://www.ncbi.nlm.nih.gov/pubmed/34733840 http://dx.doi.org/10.3389/fcell.2021.720649 |
Ejemplares similares
-
Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus
por: Zeng, Yongji, et al.
Publicado: (2023) -
Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network
por: Lu, Donglan, et al.
Publicado: (2020) -
Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
por: Pan, Jingjing, et al.
Publicado: (2022) -
Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021) -
PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma
por: Ni, Zhizhan, et al.
Publicado: (2021)